Between assemblies, a board of 17 directors, elected by the General Assembly, act as the executive body of UICC.
The following individuals have been elected:
Benjamin O. Anderson (United States)
Benjamin O. Anderson, MD is a Professor of Surgery and Global Health-Medicine at the University of Washington School of Medicine in Seattle, Joint Member in Public Health Sciences at the Fred Hutchinson Cancer Research Center (FHCRC) and Director of the Breast Health Clinic at the Seattle Cancer Care Alliance (SCCA). Dr Anderson trained in surgical oncology as an American Cancer Society Clinical Oncology Fellow at the Memorial Sloan-Kettering Cancer Center in New York. Dr Anderson serves as Chair and Director of the Breast Health Global Initiative (BHGI) to address breast healthcare guideline development and implementation in low- and middle-income countries.
Heather Bryant (Canada)
Maira Caleffi (Brazil)
Anil D'Cruz (India)
Jeff Dunn (Australia)
With a PhD in sociology, I have over 20 years of experience in cancer control. I am the CEO of a Member Organisation with a long history of supporting the UICC. I have served the UICC since 1991, as a Strategic Leader and Capacity Building Fund Chairperson. I am currently a Member of the World Leaders’ Forum. I bring strong links to international cancer programs as President of the Asian Pacific Organisation for Cancer Prevention, Chair of the Asia Pacific Cancer Society Training Grant Program, Chair of Reach to Recovery International and Secretary of the International Psycho-Oncology Society.
Serigne Gueye (Senegal)
Dr Serigne Gueye is Professor and Chair of Urology at the Grand Yoff General Hospital and University Cheikh Anta DIOP, Dakar, Senegal. He is former Fulbright scholar at University of Pennsylvania, USA. He is President of ALIAM (Alliance of African and Mediterranean Leagues against cancer) and the Senegalese Society of Cancer (SOSECAN). He is Past President of AORTIC. He received in 2011 the AACR Landon Award for excellence in international collaboration on cancer research. Field surgeon during the Rwandese genocide (1994), Dr Gueye was recipient of United Nations’ Medal for Peace and many other medals in Senegal, Chad and France.
Xishan Hao (China)
Jamal Khader (Jordan)
Dr Jamal Khader is a consultant Radiation oncologist at King Hussein Cancer Center in Amman, Jordan. He is Director of the International Affairs Center and the Director of the Radiation oncology Residency programme, Head of the Lung Cancer Service, and serves on several institutional committees such as the Graduate Medical Education Committee. Dr Khader is a member of local, regional and international committees and associations. He is the Chairman of the scientific committee of the Jordanian Oncology Society, and member of the editorial board of the Pan Arab Oncology journal as well as a member in the Jordanian Chapter of the Mediterranean Task Force for Cancer Control.
Harpal Kumar (United Kingdom)
I studied Chemical Engineering at Cambridge University and gained an MBA from Harvard Business School. After working as a research scientist with the UK Atomic Energy Authority, I joined McKinsey, advising pharmaceutical clients and health care organisations. I then became CEO of The Papworth Trust, providing pioneering rehabilitation services for people with acquired disabilities. In 1997 I became CEO of Nexan, a medical device company creating novel cardio-respiratory monitoring technologies. I joined Cancer Research UK in 2002, becoming COO in 2004 and CEO in 2007. I chair the UK’s National Cancer Research Institute and the National Awareness and Early Diagnosis Initiative.
Gilbert Lenoir (France)
Gilbert Lenoir is Professor of Medical genetics. He is a Board Member (since 1998) and past President (2010-2012) of the “Ligue Française contre le Cancer” (the major French Cancer charity). He has dedicated his entire career to cancer. A scientist at the Interna- tional Agency for Research on Cancer (IARC – Lyon, France), and professor at the medical school, he was appointed as Deputy Director in charge of research at the Institut Gustave Roussy, Villejuif in 2000. Since 2010 he has been in charge of the Paris biocluster programme: Cancer Campus. He is the author of more than 400 articles in cancer genetics, epidemiological and translational research.
Tetsuo Noda (Japan)
Tetsuo Noda, MD, PhD is the Representative Director of Japanese Foundation for Cancer Research (JFCR), the largest foundation for cancer research and treatment in Japan. He also serves as a president of the Japanese Cancer Association (JCA), the largest association of cancer researchers in Japan. He graduated from Tohoku University School of Medicine in 1980 and obtained a PhD on the study of tumor immunology in 1984. After postdoctoral training in the US (NCI and MIT), he became a professor of molecular genetics of Tohoku University School of Medicine in 1998. He has been a member of fellowship committee of UICC since 2007.
Anne-Lise Ryel (Norway)
Anne Lise Ryel was born in Tromsø, Norway, in 1958. She obtained a Law Degree at the University of Oslo in 1987. She worked as Junior Lawyer at Hjort DA from 1988 and then as Lawyer at a Hydro-power Grid Company, Statnett SF, from 1992 to 1994 until her appointment as the Norwegian Gender Equality Ombudsman. She served as State Secretary at the Ministry of Justice in the Stoltenberg First Government in 2001 and as Deputy Director General at the Norwegian Directorate of Health in 2002. Ms. Ryel has been Secretary General of the Norwegian Cancer Society since 2002.
Saunthari Somasundaram (Malaysia)
Dr Saunthari studied medicine in Dublin, Ireland and then worked in Paediatrics in Malaysia and the U.K. During the course of her career she completed her MBA with the University of Bath. On return to Malaysia, she went on to take on various key positions in the National Cancer Society of Malaysia (NCSM) and is now serving as its Medical Director, giving her extensive experience in operations as well as clinical and educational services and counselling. She was elected as the President of NCSM in 2010 where she is responsible for the overall strategic direction and vision of the Society.
Richard Sullivan (United Kingdom)
I was raised in the Middle East and East Africa before coming back the UK where I studied medicine at St. Marys Hospital, Paddington. After training in academic uro-oncology surgery, I joined Cancer Research UK as clinical director. After CRUK I led the emerging countries health, population and society theme at London School of Economics before joining Kings Health Partners as Chair, Cancer Policy and Global Health. At KHP I direct the Institute of Cancer Policy which focuses on global cancer health, and the Kings Conflict & Health program, particularly around NCD control in fragile countries.